Vaporizing Chest

Description

Vaporizing Chest Rub is a cough suppressant formulated for topical application. It is presented in a net weight of 4 ounces (113 grams). The product is designed to provide symptomatic relief for cough associated with colds and respiratory conditions through its vaporizing properties.

Uses and Indications

This drug is indicated for the temporary relief of cough associated with common colds and minor bronchial irritation. It is intended for application on the chest and throat to help decrease, suppress, quiet, and alleviate cough symptoms.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults and children aged 2 years and older, a thick layer of the product should be applied to the chest and throat, or it may be rubbed onto sore, aching muscles. It is recommended to keep clothing loose around the chest and throat to facilitate the inhalation of vapors through the nose and mouth.

The application may be repeated up to three times within a 24-hour period, or as directed by a healthcare professional. It is important to note that the product should not be used on children under 2 years of age unless specifically directed by a physician.

Contraindications

Use is contraindicated in children under 2 years of age unless directed by a physician. This precaution is necessary to ensure safety and efficacy in this age group.

Warnings and Precautions

For external use only; contact with eyes should be strictly avoided. This product is not intended for oral use, nor should it be applied in the nostrils, under tight bandages, or on wounds or damaged skin.

Healthcare professionals should advise patients to consult a physician prior to use if they experience a cough accompanied by excessive phlegm (mucus) or if they have a persistent or chronic cough, particularly in cases of asthma, emphysema, or smoking history.

During the application of this product, it is imperative to avoid heating, microwaving, or adding it to hot water or any container that may contain heated water, as this may lead to splattering and potential burns.

Patients should be instructed to discontinue use and seek medical advice if the cough persists for more than 7 days, recurs, or is accompanied by fever, rash, or a persistent headache, as these symptoms may indicate a serious underlying condition. Additionally, if muscle aches and pain last longer than 7 days or return, medical consultation is recommended.

Side Effects

Patients using this product should be aware of several important warnings and precautions. This product is intended for external use only and should not come into contact with the eyes. It is contraindicated for oral use, application in the nostrils, use with tight bandages, or on wounds or damaged skin. Patients are advised to consult a healthcare professional prior to use if they have a cough that produces excessive phlegm or if they experience a persistent or chronic cough associated with conditions such as asthma, emphysema, or smoking.

While using this product, patients must avoid heating, microwaving, or adding it to hot water or any container that may contain heated water, as this may lead to splattering and result in burns.

Patients should discontinue use and seek medical advice if their cough persists for more than 7 days, recurs, or is accompanied by fever, rash, or a persistent headache, as these symptoms may indicate a serious underlying condition. Additionally, if muscle aches and pain last longer than 7 days or return, patients should also consult a healthcare provider.

Drug Interactions

No specific drug interactions have been identified in the available data. Additionally, there are no reported interactions with laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on the current information.

Packaging & NDC

Below are the non-prescription pack sizes of Vaporizing Chest (camphor, menthol, eucalyptus). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 2 years of age should not use this product unless directed by a physician. For children aged 2 years and older, the recommended application involves rubbing a thick layer on the chest and throat or on sore, aching muscles. It is advised to keep clothing loose around the chest and throat to facilitate the inhalation of vapors. This application may be repeated up to three times within a 24-hour period or as directed by a healthcare professional.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

There is no information available regarding the use of Vaporizing Chest (camphor, menthol, eucalyptus salve) during pregnancy. Consequently, the safety of this product in pregnant patients has not been established, and there are no specific dosage modifications or special precautions recommended for use in this population. Healthcare professionals should exercise caution and consider the lack of data when advising women of childbearing potential regarding the use of this product during pregnancy.

Lactation

There are no specific warnings or recommendations regarding the use of this product by lactating mothers. Additionally, there are no statements concerning the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of information necessitates careful clinical judgment and monitoring.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise, as the clinical presentation can vary depending on the substance involved and the individual patient's response. Common symptoms of overdose may include, but are not limited to, altered mental status, cardiovascular instability, and respiratory distress.

In the event of an overdose, immediate medical intervention is recommended. Healthcare providers should initiate supportive care, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs. The use of activated charcoal may be considered if the patient presents within a suitable timeframe and is deemed appropriate based on clinical judgment.

Additionally, it is crucial to consult local poison control centers or toxicology experts for guidance on specific management protocols and antidotes, if applicable. Continuous assessment and supportive measures should be prioritized to ensure patient safety and mitigate potential complications associated with overdose.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients that the medication is not recommended for use in children under 2 years of age unless specifically directed by a physician. It is important for patients to understand the potential risks associated with administering this medication to young children without medical guidance. Providers should encourage patients to consult with their healthcare professional if they have any questions or concerns regarding the use of this medication in pediatric populations.

Storage and Handling

The product is supplied in a configuration that ensures optimal handling and storage. It should be stored at room temperature, away from heat sources to maintain its integrity. It is essential to keep the container tightly closed when not in use to prevent contamination and degradation.

Special handling precautions must be observed: the product must not be microwaved or added to hot water, nor should it be placed in any container where heating water may occur. These measures are critical to ensure the product remains effective and safe for use.

Additional Clinical Information

The product is administered topically and may be applied up to three times within a 24-hour period, or as directed by a healthcare professional. Clinicians should advise patients not to use the product on children under 2 years of age unless specifically directed by a doctor. It is important to avoid contact with the eyes and not to apply the product by mouth, in nostrils, with tight bandages, or on wounds or damaged skin.

Patients should be counseled to consult a doctor before use if they have a cough accompanied by excessive phlegm, or if they experience a persistent or chronic cough associated with conditions such as asthma, emphysema, or smoking. Additionally, patients should refrain from heating the product, as this may cause splattering and burns. They should discontinue use and seek medical advice if their cough persists for more than 7 days, recurs, or is accompanied by fever, rash, or a persistent headache, as these may indicate a serious condition. Muscle aches and pain that last more than 7 days or return should also prompt a consultation with a healthcare provider.

Drug Information (PDF)

This file contains official product information for Vaporizing Chest, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)